Clinical utility of linear endosonography in patients with unexplained biliary dilatation and negative MRCP, with predictors for detection of neoplastic lesions

Egyptian Liver Journal

Table 3 Comparison between groups A versus B

	Group A No = 29	Group B No = 32	P value
Age	60 (21–82)	59 (33–79)	0.426
Sex
• Male	13 (44.8%)	16 (50.0%)	0.686
• Female	16 (55.2%)	16 (50.0%)	0.686
Clinical presentation
• Jaundice	26 (89.7%)	17 (53.1%)	0.002
• Abdominal pain	2 (6.9%)	8 (25.0%)	0.056
• Incidental biliary dilatation	2 (3.4%)	7 (21.9%)	0.033
Laboratory data
• Total bilirubin	5.3 (0.4–37.0)	1.4 (0.5–39.0)	0.002
• ALT	54.0 (21.0–201.0)	45.5(11.0–239.0)	0.466
• AST	50.0 (23.0–288.0)	44.0(19.0–210.0)	0.355
• Alkaline phosphatase	250 (160–1260)	190 (47–647)	0.022
CBD diameter by EUS	13.7 ± 2.92	11.55 ± 3.14	0.006